The New Urgency of Clinical Trials: How Oncology Leads the Evolution

Join colleagues from the research community for a discussion on the evolution of clinical trials and how oncology research has influenced agility in clinical trial design.

In forcing rapid transformation in the clinical research space, the COVID-19 pandemic has encouraged the use of many modalities pioneered in oncology studies. Oncology has long been an early adopter of research innovations, such as gene therapy, cross-organization collaboration, and novel protocol design.

In this expert panel discussion, representatives from industry and academia explore the unique ways oncology has led the charge in clinical trial advancements, consider how the urgency of COVID-19 has affirmed and propelled oncology’s ground-breaking contributions, and examine how the mainstream attention on clinical trial participation and diversity of volunteers will impact the oncology space to anticipate the future of clinical trials.

This virtual event is free—don’t miss this timely, engaging symposium.

Discussion Topics:

• Identify key oncology innovations that have sparked advancements in other therapeutic areas and empowered COVID-19 research
• Describe how the COVID-19 pandemic has encouraged virtual capabilities in oncology, such as telemedicine and eConsent
• Discuss the future of clinical trials participation through the lens of oncology research

Cost to Attend:

Free

Presented By